Segments and Geographic Information

12 Months Ended

May 31, 2016

Segment Reporting [Abstract]

SEGMENTS AND GEOGRAPHIC INFORMATION

SEGMENTS AND GEOGRAPHIC INFORMATION

Segment information

We consider our business to be a single segment entity related to the development, manufacture and sale on a global basis of medical devices for vascular access, surgery, peripheral vascular disease and oncology. Our chief operating decision maker (CEO) evaluates the various global product portfolios on a net sales basis. Executives reporting in to the CEO include those responsible for operations and supply chain management, research and development, sales, franchise marketing and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources.

Total sales by product category are summarized below (in thousands):

	Year Ended
	May 31, 2016		May 31, 2015		May 31, 2014
Net sales by Product Category
Peripheral Vascular	$	202,780	$	192,713	$	192,626
Vascular Access	99,375		107,754		106,394
Oncology/Surgery	48,895		51,890		49,360
Supply Agreement	2,840		4,177		6,045
Total	$	353,890	$	356,534	$	354,425

Geographic information

Total sales for geographic areas are summarized below (in thousands):

	Year Ended
	May 31, 2016		May 31, 2015		May 31, 2014
Net sales by Geography
United States	$	283,519	$	280,611	$	280,161
International	67,531		71,746		68,219
Supply Agreement	2,840		4,177		6,045
Total	$	353,890	$	356,534	$	354,425

For fiscal years 2016, 2015 and 2014, International sales as a percentage of total net sales were 19%, 20% and 19%, respectively. Sales to any one country outside the U.S., as determined by shipment destination, did not comprise a material portion of our net sales in any of the last three fiscal years. 99% of our total assets are located within the United States.